Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedRecruitment status updated to show that no more participants are being sought. A new revision tag v3.6.0 has been added, replacing the previous v3.5.5.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing v3.5.4. This indicates a deployment update to the history page rather than changes to study data or content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page footer now shows 'Revision: v3.5.4' replacing 'v3.5.3'. This indicates a minor platform update to the page rendering rather than a change to study data.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page footer updated to show Revision: v3.5.3, indicating a new page version. The core study record content remains unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer now shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.